Network modulation in the treatment of Parkinson's disease

Brain

Volumn 129, Issue 10, 2006, Pages 2667-2678

  Asanuma, Kotaro ^a,b   Tang, Chengke ^a,b   Ma, Yilong ^a,b   Dhawan, Vijay ^a,b   Mattis, Paul ^a,b   Edwards, Christine ^a,b   Kaplitt, Michael G ^c   Feigin, Andrew ^a,b   Eidelberg, David ^a,b  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Brain metabolism; Deep brain stimulation; Parkinson s disease; PET; Subthalamic nucleus

Indexed keywords

GLUCOSE; LEVODOPA;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN METABOLISM; BRAIN REGION; CEREBELLUM VERMIS; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; GLOBUS PALLIDUS; HUMAN; INTERMETHOD COMPARISON; MALE; PARKINSON DISEASE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUTAMEN; SENSORIMOTOR CORTEX; STATISTICAL ANALYSIS; SUBTHALAMIC NUCLEUS; TREATMENT RESPONSE;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIPARKINSON AGENTS; CEREBELLUM; DEEP BRAIN STIMULATION; FEMALE; FLUORODEOXYGLUCOSE F18; GLOBUS PALLIDUS; GLUCOSE; HUMANS; LEVODOPA; LINEAR MODELS; MALE; MIDDLE AGED; MOTOR CORTEX; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; PUTAMEN; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 33749468221     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awl162     Document Type: Article

References (74)

1. Asanuma K, Ma Y, Huang C, Carbon M, Edwards C, Raymond D, et al. The metabolic pathology of dopa-responsive dystonia. Ann Neurol 2005; 57: 596-600.
2. Beck A. Beck depression inventory: manual. San Antonio: Psychological Corporation; 1987.
3. Benabid AL. Deep brain stimulation for Parkinson's disease. Curr Opin Neurobiol 2003; 13: 696-706.
4. Benazzouz A, Hallett M. Mechanism of action of deep brain stimulation. Neurology 2000; 55: S13-6.
5. Benton A, Hamsher K, Sivan A. Multilingual aphasia examination. Vol. 3rd edn. Iowa City: AJA Associates; 1994.
6. Beurrier C, Bioulac B, Audin J, Hammond C. High-frequency stimulation produces a transient blockade of voltage-gated currents in subthalamic neurons. J Neurophysiol 2001; 85: 1351-56.
7. Blesa R, Blin J, Miletich R. Levodopa-reduced glucose metabolism in striatopallido-thalamocortical circuit in Parkinson's disease. Neurology 1991; 441: 359.
8. Brandt J, Benedict R. Hopkins Verbal Learning Test-Revised Manual. Odessa: Psychological Assessment Resources; 2001.
9. Carbon M, Eidelberg D. Modulation of regional brain function by deep brain stimulation: studies with positron emission tomography. Curr Opin Neurol 2002; 15: 451-5.
10. Carbon M, Edwards C, Eidelberg D. Functional brain imaging in Parkinson's disease. Adv Neurol 2003a; 91: 175-81.
11. Carbon M, Ghilardi MF, Feigin A, Fukuda M, Silvestri G, Mentis MJ, et al. Learning networks in health and Parkinson's disease: reproducibility and treatment effects. Hum Brain Mapp 2003b; 19: 197-211.
12. Ceballos-Baumann AO, Boecker H, Bartenstein P, von Falkenhayn I, Riescher H, Conrad B, et al. A positron emission tomographic study of subthalamic nucleus stimulation in Parkinson disease: enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity. Arch Neurol 1999; 56: 997-1003.
13. Chudasama Y, Baunez C, Robbins TW. Functional disconnection of the medial prefrontal cortex and subthalamic nucleus in attentional performance: evidence for corticosubthalamic interaction. J Neurosci 2003; 23: 5477-85.
14. Dostrovsky JO, Levy R, Wu JP, Hutchison WD, Tasker RR, Lozano AM. Microstimulation-induced inhibition of neuronal firing in human globus pallidus. J Neurophysiol 2000; 84: 570-4.
15. Efron B, Tibshirani R. An introduction to the bootstrap. New York: CRC Press, LLC; 1994.
16. Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, et al. The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 1994; 14: 783-801.
17. Eidelberg D, Moeller JR, Ishikawa T, Dhawan V, Spetsieris P, Silbersweig D, et al. Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease. Ann Neurol 1996; 39: 450-9.
18. Eidelberg D, Moeller JR, Kazumata K, Antonini A, Sterio D, Dhawan V, et al. Metabolic correlates of pallidal neuronal activity in Parkinson's disease. Brain 1997; 120: 1315-24.
19. Eidelberg D, Edwards C, Mentis M, Dhawan V, Moeller JR. Movement disorders: Parkinson's disease. In: Mazziotta JC, Toga AW, Frackowiak RSJ, editors. Brain mapping: the disorders. San Diego: Academic Press; 2000. p. 241-61.
20. Fahn S, Elton RL. Unified Parkinson's Disease Rating Scale. Recent Developments in Parkinson's Disease. In: Fahn S, Marsden CD, Calne DB, editors. Florham Park: MacMillan Health Care Information; 1987. p. 153-63.
21. Feigin A, Fukuda M, Dhawan V, Przedborski S, Jackson-Lewis V, Mentis MJ, et al. Metabolic correlates of levodopa response in Parkinson's disease. Neurology 2001; 57: 2083-8.
22. Filali M, Hutchinson WD, Palter VN, Lozano AM, Dostrovsky J. Stimulation-induced inhibition of neuronal firing in human subthalamic nucleus. Exp Brain Res 2004; 156: 274-81.
23. Fukuda M, Mentis MJ, Ma Y, Dhawan V, Antonini A, Lang AE, et al. Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism. Brain 2001; 124: 1601-9.
24. Funkiewiez A, Ardouin C, Caputo E, Krack P, Fraix V, Klinger H, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75: 834-9.
25. Goerendt IK, Lawrence AD, Mehta MA, Stern JS, Odin P, Brooks DJ. Distributed neural actions of anti-parkinsonian therapies as revealed by PET. J Neural Transm 2006; 113: 75-86.
26. Goldberg JA, Boraud T, Maraton S, Haber SN, Vaadia E, Bergman H. Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-12,3,6- tetrahydropyridine primate model of Parkinson's disease. J Neurosci 2002; 22: 4639-53.
27. Grady CL, McIntosh AR, Craik FI. Task-related activity in prefrontal cortex and its relation to recognition memory performance in young and old adults. Neuropsychologia 2005; 43: 1466-81.
28. Hamani C, Saint-Cyr JA, Fraser J, Kaplitt M, Lozano AM. The subthalamic nucleus in the context of movement disorders. Brain 2004; 127: 4-20.
29. Hashimoto T, Elder CM, Okun MS, Patrick SK, Vitek JL. Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. J Neurosci 2003; 23: 1916-23.
30. Haslinger B, Kalteis K, Boecker H, Alesch F, Ceballos-Baumann AO. Frequency-correlated decreases of motor cortex activity associated with subthalamic nucleus stimulation in Parkinson's disease. Neuroimage 2005; 28: 598-606.
31. Hershey T, Black KJ, Carl JL, Perlmutter JS. Dopa-induced blood flow responses in nonhuman primates. Exp Neurol 2000; 166: 342-9.
32. Hershey T, Revilla FJ, Wernle AR, McGee-Minnich L, Antenor JV, Videen TO, et al. Cortical and subcortical blood flow effects of subthalamic nucleus stimulation in PD. Neurology 2003; 61: 816-21.
33. Hilker R, Voges J, Thiel A, Ghaemi M, Herholz K, Sturm V, et al. Deep brain stimulation of the subthalamic nucleus versus levodopa challenge in Parkinson's disease: measuring the on- and off-conditions with FDG-PET. J Neural Transm 2002; 109: 1257-64.
34. Hilker R, Voges J, Ghaemi M, Lehrke R, Rudolf J, Koulousakis A, et al. Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans. Mov Disord 2003; 18: 41-8.
35. Hilker R, Voges J, Weisenbach S, Kalbe E, Burghaus L, Ghaemi M, et al. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease. J Cereb Blood Flow Metab 2004; 24: 7-16.
36. Huang C, Feigin A, Ma Y, Eidelberg D. Imaging measures of longitudinal change in Parkinson's disease. Neurology 2005; 64: A235.
37. Kaasinen V, Nagren K, Hietala J, Oikonen V, Vilkman H, Farde L, et al. Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease. Neurology 2000; 54: 1482-7.
38. Krack P, Fraix V, Mendes A, Benabid AL, Pollak P. Postoperative management of subthalamic nucleus stimulation for Parkinson's disease. Mov Disord 2002; 17: 188-97.
39. Levy R, Ashby P, Hutchison WD, Lang AE, Lozano AM, Dostrovsky JO. Dependence of subthalamic nucleus oscillations on movement and dopamine in Parkinson's disease. Brain 2002; 125: 1196-209.
40. Lewis DA, Sesack SR. Dopamine systems in the primate brain. In: Bloom FE, Bjorklund A, Hokfelt T, editors. Handbook of chemical neuroanatomy, the primate nervous system, Pt I. New York: Elsevier Science; 1997. p. 261-373.
41. Limousin P, Greene J, Pollak P, Rothwell J, Benabid AL, Frackowiak R. Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Ann Neurol 1997; 42: 283-91.
42. Lozano AM, Mahant N. Deep brain stimulation surgery for Parkinson's disease: mechanisms and consequences. Parkinsonism Relat Disord 2004; 10 (Suppl 1): S49-57.
43. Lozano AM, Lang AE, Levy R, Hutchison W, Dostrovsky J. Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine. Ann Neurol 2000; 47: S141-6.
44. Lozza C, Baron JC, Eidelberg D, Mentis MJ, Carbon M, Marie RM. Executive processes in Parkinson's disease: FDG-PET and network analysis. Hum Brain Mapp 2004; 22: 236-45.
45. Mattay VS, Fera F, Tessitore A, Hariri AR, Das S, Callicott JH, et al. Neurophysiological correlates of age-related changes in human motor function. Neurology 2002; 58: 630-5.
46. Maurice N, Deniau JM, Glowinski J, Thierry AM. Relationships between the prefrontal cortex and the basal ganglia in the rat: physiology of the corticosubthalamic circuits. J Neurosci 1998; 18: 9539-46.
47. McIntyre CC, Savasta M, Kerkerian-Le Goff L, Vitek JL. Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both. Clin Neurophysiol 2004a; 115: 1239-48.
48. McIntyre CC, Savasta M, Walter BL, Vitek JL. How does deep brain stimulation work? Present understanding and future questions. J Clin Neurophysiol 2004b; 21: 40-50.
49. Middleton FA, Strick PL. Basal-ganglia 'projections' to the prefrontal cortex of the primate. Cereb Cortex 2002; 12: 926-35.
50. Moeller JR, Nakamura T, Mentis MJ, Dhawan V, Spetsieres P, Antonini A, et al. Reproducibility of regional metabolic covariance patterns: comparison of four populations. J Nucl Med 1999; 40: 1264-9.
51. Neal JW, Pearson RC, Powell TP. The ipsilateral corticocortical connections of area 7 with the frontal lobe in the monkey. Brain Res 1990; 509: 31-40.
52. Nelson HE. The National Adult Reading Test (NART): Test Manual. Windsor, UK: NFER-Nelson; 1982.
53. Parent A, Hazrati LN. Functional anatomy of the basal ganglia. The corticobasal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev 1995a; 20: 91-127.
54. Parent A, Hazrati LN. Functional anatomy of the basal ganglia. I. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev 1995b; 20: 128-54.
55. Parent A, Cossete M, Levesque M. Anatomical considerations in basal ganglia surgery. In: Lozano AM, editor. Movement disorder surgery. Progress in neurological surgery. Vol 15. Basel: Karger; 2000. p. 21-30.
56. Payoux P, Remy P, Damier P, Miloudi M, Loubinoux I, Pidoux B, et al. Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease. Arch Neurol 2004; 61: 1307-13.
57. Peppe A, Pierantozzi M, Bassi A, Altibrandi MG, Brusa L, Stefani A, et al. Stimulation of the subthalamic nucleus compared with the globus pallidus internus in patients with Parkinson disease. J Neurosurg 2004; 101: 195-200.
58. Pillon B, Ardouin C, Damier P, Krack P, Houeto JL, Klinger H, et al. Neuropsychological changes between 'off' and 'on' STN or GPi stimulation in Parkinson's disease. Neurology 2000; 55: 411-8.
59. Price CJ, Friston KJ. Cognitive conjunction: a new approach to brain activation experiments. Neuroimage 1997; 5: 261-70.
60. Saint-Cyr JA, Trepanier LL, Kumar R, Lozano AM, Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000; 123: 2091-108.
61. Schretlen D. Brief Test of Attention. Odessa: Psychological Assessment Resources; 1989.
62. Seamans JK, Yang CR. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 2004; 74: 1-58.
63. Smith A. Symbol Digit Modalities Test (SDMT): Manual (Revised). Los Angeles: Western Psychological Services; 1982.
64. Su PC, Ma Y, Fukuda M, Mentis MJ, Tseng HM, Yen RF, et al. Metabolic changes following subthalamotomy for advanced Parkinson's disease. Ann Neurol 2001; 50: 514-20.
65. Taktakishvili O, Sivan-Loukianova E, Kultas-Ilinksky K, Ilinsky IA. Posterior parietal cortex projections to the ventral lateral and some association thalamic nuclei in Macaca mulatta. Brain Res Bull 2002; 59: 135-50.
66. Talairach J, Tournoux P. Coplanar stereotaxic atlas of the human brain. New York: Thieme Medical; 1988.
67. Trošt M, Su PC, Barnes A, Su SL, Yen RF, Tseng HM, et al. Evolving metabolic changes during the first postoperative year after subthalamotomy. J Neurosurg 2003; 99: 872-8.
68. Trošt M, Su S, Su PC, Yen R-F, Tseng H-M, Barnes A, et al. Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease. Neuroimage 2006; 31: 301-7.
69. Vafaee MS, K OS, Sunde N, Gjedde A, Dupont E, Cumming P. Focal changes of oxygen consumption in cerebral cortex of patients with Parkinson's disease during subthalamic stimulation. Neuroimage 2004; 22: 966-74.
70. Vingerhoets FJ, Villemure JG, Temperli P, Pollo C, Pralong E, Ghika J. Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up. Neurology 2002; 58: 396-401.
71. Vitek JL, Giroux M. Physiology of hypokinetic and hyperkinetic movement disorders: model for dyskinesia. Ann Neurol 2000; 47: S131-40.
72. Volkmann J. Deep brain stimulation for the treatment of Parkinson's disease. J Clin Neurophysiol 2004; 21: 6-17.
73. Wichmann T, DeLong MR. Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol 1996; 6: 751-8.
74. Yeterian EH, Pandya DN. Corticothalamic connections of the posterior parietal cortex in the rhesus monkey. J Comp Neurol 1985; 237: 408-26.